RENEE FRAWLEY: Open Payments
NPI 1508175258 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 109 payments from 17 companies in 2025. Trend: 2023 $336 · 2024 $1,719 · 2025 $1,904
Food & beverage: $1,893Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $401 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $296 |
| Janssen Biotech, Inc. | 11 | $224 |
| Madrigal Pharmaceuticals | 5 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $148 |
| PFIZER INC. | 5 | $119 |
| Regeneron Healthcare Solutions, Inc. | 3 | $106 |
| Ardelyx, Inc. | 4 | $103 |
| Gilead Sciences, Inc. | 3 | $60 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
Products named: XIFAXAN, TREMFYA, RINVOQ, REZDIFFRA, LINZESS, DUPIXENT, XELJANZ, IBSRELA.
Industry payments across NY — which companies pay providers there.
